Fundamentals Platelet-rich plasma (PRP) has been progressively more used in androgenetic alopecia (AGA). Objectives The authors aimed to evaluate PRP efficacy compared to placebo in AGA. Methods A ...

Prevalence of FPHL increases with age; 12% of females will have symptoms by age 29 years, 25% by age 50 years, and 41% to 50% at age 70 years and older.[1][1] Risk factors include genetics and ...

According to Ayesha Bashir, prescribing pharmacist and hair loss expert, more than 15 million Brits are affected by some form of hair loss. Among women, the issue is particularly common during midlife ...